Q6IDD9
Gene name |
Sarm (Ect4, CG43119) |
Protein name |
NAD |
Names |
+ hydrolase sarm1 , NADase sarm1 , EC 3.2.2.6 , Sterile alpha and TIR motif-containing protein 1 , Tir-1 homolog |
Species |
Drosophila melanogaster (Fruit fly) |
KEGG Pathway |
dme:Dmel_CG43119 |
EC number |
3.2.2.6: Hydrolyzing N-glycosyl compounds |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
837-981 (TIR domain) |
Relief mechanism |
Others |
Assay |
|
Accessory elements
No accessory elements
References
- Bratkowski M et al. (2020) "Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1", Cell reports, 32, 107999
- Summers DW et al. (2016) "SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation", Proceedings of the National Academy of Sciences of the United States of America, 113, E6271-E6280
- Sasaki Y et al. (2021) "Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection", Experimental neurology, 345, 113842
- Bloom AJ et al. (2022) "Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients", Molecular neurodegeneration, 17, 1
- Shen C et al. (2021) "Multiple domain interfaces mediate SARM1 autoinhibition", Proceedings of the National Academy of Sciences of the United States of America, 118,
- Khazma T et al. (2022) "A duplex structure of SARM1 octamers stabilized by a new inhibitor", Cellular and molecular life sciences : CMLS, 80, 16
Autoinhibited structure

Activated structure

5 structures for Q6IDD9
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
7LCY | X-ray | 335 A | A/B/C | 314-678 | PDB |
7LCZ | X-ray | 165 A | A/B | 370-678 | PDB |
7M6K | X-ray | 169 A | A/B | 369-678 | PDB |
7RTC | X-ray | 331 A | A/B/C | 315-678 | PDB |
AF-Q6IDD9-F1 | Predicted | AlphaFoldDB |
No variants for Q6IDD9
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q6IDD9 |
No associated diseases with Q6IDD9
3 regional properties for Q6IDD9
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Toll/interleukin-1 receptor homology (TIR) domain | 837 - 981 | IPR000157 |
domain | Sterile alpha motif domain | 687 - 754 | IPR001660-1 |
domain | Sterile alpha motif domain | 757 - 826 | IPR001660-2 |
Functions
Description | ||
---|---|---|
EC Number | 3.2.2.6 | Hydrolyzing N-glycosyl compounds |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
5 GO annotations of cellular component
Name | Definition |
---|---|
axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
4 GO annotations of molecular function
Name | Definition |
---|---|
NAD+ nucleosidase activity | Catalysis of the reaction |
NAD+ nucleotidase, cyclic ADP-ribose generating | Catalysis of the reaction |
signaling adaptor activity | The binding activity of a molecule that brings together two or more molecules in a signaling pathway, permitting those molecules to function in a coordinated way. Adaptor molecules themselves do not have catalytic activity. |
STAT family protein binding | Binding to a member of the signal transducers and activators of transcription (STAT) protein family. STATs are, as the name indicates, both signal transducers and transcription factors. STATs are activated by cytokines and some growth factors and thus control important biological processes including cell growth, cell differentiation, apoptosis and immune responses. |
7 GO annotations of biological process
Name | Definition |
---|---|
antiviral innate immune response | A defense response against viruses mediated through an innate immune response. An innate immune response is mediated by germline encoded components that directly recognize components of potential pathogens. |
defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
NAD catabolic process | The chemical reactions and pathways resulting in the breakdown of nicotinamide adenine dinucleotide, a coenzyme present in most living cells and derived from the B vitamin nicotinic acid; catabolism may be of either the oxidized form, NAD, or the reduced form, NADH. |
negative regulation of MyD88-independent toll-like receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-independent toll-like receptor signaling pathway. |
positive regulation of receptor signaling pathway via STAT | Any process that activates or increases the frequency, rate or extent of receptor signaling pathway via STAT. |
response to axon injury | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
5 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q6SZW1 | SARM1 | NAD hydrolase SARM1 hydrolase SARM1) | Homo sapiens (Human) | EV |
Q6PDS3 | Sarm1 | NAD | Mus musculus (Mouse) | SS |
I3L5V6 | SARM1 | NAD | Sus scrofa (Pig) | SS |
D3ZUM2 | Sarm1 | NAD | Rattus norvegicus (Rat) | SS |
F1QWA8 | sarm1 | NAD | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MKAAEIKRDL | TNIQKSMSEI | NDLAKERITG | GPGSISTTSA | SAITAPSTMS | QTTTSRLAPK |
70 | 80 | 90 | 100 | 110 | 120 |
LTSAHPSIDD | LRGLSRQDKI | TQLQKKIRAS | FENLVDHDDS | NVIVTLPDDD | DCPHNHFGSG |
130 | 140 | 150 | 160 | 170 | 180 |
LNLTHPTAAQ | LSASGLSGSS | KTIDTIKFQE | KSMKTESKTK | VVTDGFSSEQ | ATSNSAEMKR |
190 | 200 | 210 | 220 | 230 | 240 |
LQAGDIDYQE | SKGASAMRNR | LEVDGVKTEE | NAAVIKEALS | LRTGDITQQA | SNNVAASSIT |
250 | 260 | 270 | 280 | 290 | 300 |
VQSENFSADK | KAISQSQQSQ | TMTSNGIISQ | EKHVSSASQA | NYSMSHKGVS | STGSSMITSS |
310 | 320 | 330 | 340 | 350 | 360 |
SQMSAMNGQM | LKLADLKLDD | LKSLTAGSGQ | QEIEQTINKY | SNMLTSIVSS | LQEDERGGSA |
370 | 380 | 390 | 400 | 410 | 420 |
ITVHDVGGKK | SQYLEKINEV | IRRAWAVPTH | GHELGYSLCN | SLRQSGGLDL | LMKNCVKPDL |
430 | 440 | 450 | 460 | 470 | 480 |
QFSSAQLLEQ | CLTTENRKHV | VDNGLDKVVN | VACVCTKNSN | MEHSRVGTGI | LEHLFKHSEG |
490 | 500 | 510 | 520 | 530 | 540 |
TCSDVIRLGG | LDAVLFECRT | SDLETLRHCA | SALANLSLYG | GAENQEEMIL | RKVPMWLFPL |
550 | 560 | 570 | 580 | 590 | 600 |
AFHNDDNIKY | YACLAIAVLV | ANKEIEAEVL | KSGCLDLVEP | FVTSHDPSAF | ARSNLAHAHG |
610 | 620 | 630 | 640 | 650 | 660 |
QSKHWLKRLV | PVLSSNREEA | RNLAAFHFCM | EAGIKREQGN | TDIFREINAI | EALKNVASCP |
670 | 680 | 690 | 700 | 710 | 720 |
NAIASKFAAQ | ALRLIGETVP | HKLSQQVPLW | SVEDVQEWVK | QIGFNDYIDK | FNESQVDGDL |
730 | 740 | 750 | 760 | 770 | 780 |
LLKLNQDNLR | ADIGIGNGIL | LKRFERELQN | LKRMADYSSK | DTAKMHQFLS | EIGTDYCTYT |
790 | 800 | 810 | 820 | 830 | 840 |
YAMLNAGIDK | CALPHVNEDM | LMTECGIHNS | IHRLRILNAV | KNLENSLPSS | SEENMAKTLD |
850 | 860 | 870 | 880 | 890 | 900 |
VFVSYRRSNG | SQLASLLKVH | LQLRGFSVFI | DVERLEAGKF | DNGLLNSIRQ | AKNFVLVLTP |
910 | 920 | 930 | 940 | 950 | 960 |
DALHRCINDE | DCKDWVHREI | VAALNSNCNI | IPIIDQQFDW | PEVERLPEDM | RSVAHFNGVN |
970 | 980 | 990 | 1000 | 1010 | 1020 |
WIHDYQDACI | DKLERFLRGE | KNIDRIAAMV | PGTPGSVSYQ | RMHSNDSDYQ | SGGAGAGSGA |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
GTGGGGGGGV | TGSVVDGLMV | AANGSGQANH | QANRYRQSPS | PARQRGSTSQ | LSGYSRAPSK |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
RSQILTPYRT | QQAALLHKTG | AGSASMQNMM | PLAYLPPRRS | SAAGLGHGSG | SGMGSGYRSH |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
SVDGLLDQAG | STPEQRIAAA | AAKVTAGSTA | LTNASSTSTL | QPEEEVTDAA | LNDSVTRRDK |
1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
HTLSPPGNVQ | QHRKSRSLDH | ILSKQTLAEL | LPPSSELADG | TQSMQNLAIP | MTPQPQRRDT |
1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
SSSSKSPTPE | RPPQPAMERV | RERQSPEGVS | ATESEREDQP | EECLRHGNQQ | RASASVHRGA |
1330 | 1340 | 1350 | |||
SLTSNKTSNS | SLGSNFSAGG | NNKTIFNRTM | KKVRSLIKKP |